Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.
Mohan A, Tiwari P, Suri TM, Mittal S, Patel A, Jain A, Velpandian T, Das US, Boppana TK, Pandey RM, Shelke SS, Singh AR, Bhatnagar S, Masih S, Mahajan S, Dwivedi T, Sahoo B, Pandit A, Bhopale S, Vig S, Gupta R, Madan K, Hadda V, Gupta N, Garg R, Meena VP, Guleria R.
. Bryant A, et al. Am J Ther. 2021 Aug 27;28(5):e573-e576. doi: 10.1097/MJT.0000000000001442. Am J Ther. 2021. PMID: 34469921
. Shah ASV, et al. N Engl J Med. 2021 Sep 8:NEJMc2106757. doi: 10.1056/NEJMc2106757. Online ahead of print. N Engl J Med. 2021. PMID: 34496200
. Yearb Med Inform. 2004. PMID: 27706321 No abstract available.